Company
ChinaHangzhou Solipharma Co., Ltd., Hangzhou, China – FDA Inspections
Inspection records and compliance data for Hangzhou Solipharma Co., Ltd. in Hangzhou. 2 FDA inspections on record, last inspected September 20, 2024.
Company Profile
This profile covers Hangzhou Solipharma Co., Ltd. based in Hangzhou, China.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected August 29, 2018. Last inspected September 20, 2024.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 20, 2024 | Not classified | Human Drugs | 1252166 |
| August 29, 2018 | NAI | Human Drugs · Drug Quality Assurance | 1066724 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Hainan Simcere Pharmaceutical Co., Ltd.
Zhejiang Yongtai Pharmaceutical Co. Ltd
Shanghai Hengrui Pharmaceutical Co., Ltd.
Haimen Pharma Co., Ltd.
Novast Laboratories Ltd.
Fosun Pharma (Xuzhou) Co., Ltd.
2Y-Biopharma, Ltd.
Simcere Pharmaceutical Co., Ltd.
Chongqing Pharscin Pharmaceutical Co., Ltd. (Banqiao Road)
OP NanoPharma Co., Ltd. Yunlin Plant
Company Information
Name
Hangzhou Solipharma Co., Ltd.
FEI Number
3013543383
Address
Ave Bldg 6th 260, 1 1st F Qiantang New Area, Hangzhou, China
Country
China
ID: 5bd44f1f-ef51-49d8-b2ed-05a3b68623a5